Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential--toward a consensus.
Tucker
G T
GT
Division of Clinical Sciences, University of Sheffield, The Royal Hallamshire Hospital, United Kingdom.
Houston
J B
JB
Huang
S M
SM
D002352:Carrier Proteins / Q000378:metabolism*; D015195:Drug Design; D004347:Drug Interactions; D007880:Legislation, Drug; D008954:Models, Biological; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010599:Pharmacokinetics; D012106:Research
D002352:Carrier Proteins; D004364:Pharmaceutical Preparations